Cargando…
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
Increasing evidence supports a close relationship between Ras-ERK1/2 activation in the striatum and L-DOPA-induced dyskinesia (LID). ERK1/2 activation by L-DOPA takes place through the crosstalk between D1R/AC/PKA/DARPP-32 pathway and NMDA/Ras pathway. Compelling genetic and pharmacological evidence...
Autores principales: | Ruiz-DeDiego, Irene, Fasano, Stefania, Solís, Oscar, Garcia-Montes, José-Rubén, Brea, José, Loza, María I., Brambilla, Riccardo, Moratalla, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194127/ https://www.ncbi.nlm.nih.gov/pubmed/30337665 http://dx.doi.org/10.1038/s41598-018-33713-3 |
Ejemplares similares
-
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia
por: Bido, Simone, et al.
Publicado: (2015) -
L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia
por: Suarez, Luz M, et al.
Publicado: (2016) -
Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation
por: Murer, Mario Gustavo, et al.
Publicado: (2011) -
Opioid system in L-DOPA-induced dyskinesia
por: Pan, Jing, et al.
Publicado: (2017) -
RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson’s disease
por: Eshraghi, Mehdi, et al.
Publicado: (2020)